Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -53.0% | -125.3% | 0 / 3 | -11.7% | +4.92 pp | -4.78 pp | +0.3% | 0.43 | 79.84 | 476 | −11,7% | −0,7 | −102,7% | 79.84 | 13.45 | +493,6% |
| Pts | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 2.940 (close price on 2026-10-19)EPS (TTM): 36,8
Financial charts
1.Revenue & growth
VND bn476Q2/26
1.Revenue & growth
VND bn476Q2/26
2.Profit & growth
VND bn6,10Q2/26
3.Profit mix (Penman)
VND bn24,3Q2/26
4.Margins & cost structure
%17.5%Q2/26
5.Returns & cash cycle
% · days0.1%Q2/26
6.Earnings quality & cash
VND bn1.422Q2/26
7.Asset structure
VND bn8.892Q2/26
8.Funding & debt health
VND bn · times8.892Q2/26
9.Revenue backlog
VND bn6,60Q2/26
10.Valuation
times · %79,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %18Q2/26
Adjusted EPS growth, latest quarter
-53.0%
Average adjusted EPS growth, 3 quarters
-125%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26